• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

诊断信息的逐步增加促使人们寻求非酒精性脂肪肝的治疗:一项随机临床试验。

Incremental levels of diagnostic information incentivize health-seeking in non-alcoholic fatty liver: a randomized clinical trial.

机构信息

Obesity and Digestive Diseases Unit and Translational Research Unit, Medica Sur Clinic and Foundation, Puente de Piedra 150 Col. Toriello Guerra Tlalpan, 14050, Mexico City, Mexico.

Center for Population Health Research, National Institute of Public Health, Cuernavaca, Mexico.

出版信息

Sci Rep. 2022 May 18;12(1):8272. doi: 10.1038/s41598-022-12295-1.

DOI:10.1038/s41598-022-12295-1
PMID:35585153
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9117664/
Abstract

Patients with chronic disorders like non-alcoholic fatty liver disease (NAFLD) face important challenges adhering to diagnostic and treatment tracks. As NAFLD increases, the need to incentivize health-seeking behaviors grows. No evidence-based interventions to address this gap exist. The aim of the study was to estimate the effect of providing increasing levels of diagnostic information on medical care-seeking in adults newly diagnosed with NAFLD. We randomly assigned adults with a sonographic diagnosis of NAFLD at a check-up unit in Mexico to one of five groups. All groups received medical consultation. A: no further interventions; B: received multimedia educational material (MEM); C: MEM + NAFLD-fibrosis-score (NFS); D: MEM + transient elastography (TE); E: MEM + NFS + TE. 1209 participants were randomized, follow-up rate 91%; 82% male, BMI 30.5 ± 4 kg/m. There were no differences in the proportion of patients undergoing further diagnostic evaluation of liver fibrosis (A 0.4%, E 0.4%, P-for-trend = 0.269). Groups who received more information sought specialized medical care more frequently: A 22%, E 30% (P-for-trend = 0.047). A trend to receive treatment was also observed at higher levels of information: A 26.7%, E 36.3% (P-for-trend = 0.134). Increasing the amount of diagnostic information seemed to increase patient's health-seeking. Tailoring the communication of information obtained for diagnosis could help to increase health-seeking in chronic disease patients.Trial registration: NCT01874249 (full date of first registration 11-06-2013).

摘要

患有非酒精性脂肪性肝病(NAFLD)等慢性疾病的患者在遵循诊断和治疗方案方面面临着重大挑战。随着 NAFLD 的增加,激励健康寻求行为的需求也在增加。目前尚无针对这一差距的循证干预措施。本研究旨在评估提供不同水平诊断信息对新诊断为 NAFLD 的成年人寻求医疗保健的影响。我们在墨西哥的一个体检单位将超声诊断为 NAFLD 的成年人随机分配到五个组之一。所有组均接受医疗咨询。A 组:无进一步干预;B 组:接受多媒体教育材料(MEM);C 组:MEM+NAFLD 纤维化评分(NFS);D 组:MEM+瞬态弹性成像(TE);E 组:MEM+NFS+TE。共有 1209 名参与者被随机分组,随访率为 91%;82%为男性,BMI 为 30.5±4kg/m。进一步诊断评估肝纤维化的患者比例在各组间无差异(A 组 0.4%,E 组 0.4%,P 趋势=0.269)。接受更多信息的组更频繁地寻求专业医疗保健:A 组 22%,E 组 30%(P 趋势=0.047)。随着信息水平的提高,接受治疗的趋势也观察到:A 组 26.7%,E 组 36.3%(P 趋势=0.134)。增加诊断信息量似乎增加了患者的健康寻求。为诊断获得的信息量身定制沟通方式可能有助于增加慢性疾病患者的健康寻求。试验注册:NCT01874249(首次注册的完整日期为 2013 年 6 月 11 日)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e172/9117664/3ba968f0ceb9/41598_2022_12295_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e172/9117664/9b3a9b4a0fb5/41598_2022_12295_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e172/9117664/3ba968f0ceb9/41598_2022_12295_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e172/9117664/9b3a9b4a0fb5/41598_2022_12295_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e172/9117664/3ba968f0ceb9/41598_2022_12295_Fig2_HTML.jpg

相似文献

1
Incremental levels of diagnostic information incentivize health-seeking in non-alcoholic fatty liver: a randomized clinical trial.诊断信息的逐步增加促使人们寻求非酒精性脂肪肝的治疗:一项随机临床试验。
Sci Rep. 2022 May 18;12(1):8272. doi: 10.1038/s41598-022-12295-1.
2
A comparison of FibroMeter™ NAFLD Score, NAFLD fibrosis score, and transient elastography as noninvasive diagnostic tools for hepatic fibrosis in patients with biopsy-proven non-alcoholic fatty liver disease.FibroMeter™非酒精性脂肪性肝病评分、非酒精性脂肪性肝病纤维化评分及瞬时弹性成像作为经活检证实的非酒精性脂肪性肝病患者肝纤维化无创诊断工具的比较
Scand J Gastroenterol. 2014 Nov;49(11):1343-8. doi: 10.3109/00365521.2014.958099. Epub 2014 Sep 26.
3
Multicenter Validation Study of a Diagnostic Algorithm to Detect NASH and Fibrosis in NAFLD Patients With Low NAFLD Fibrosis Score or Liver Stiffness.多中心验证研究:一种诊断算法,用于检测 NAFLD 患者的 NASH 和纤维化,这些患者的 NAFLD 纤维化评分或肝硬度较低。
Clin Transl Gastroenterol. 2019 Aug;10(8):e00066. doi: 10.14309/ctg.0000000000000066.
4
Evaluation and comparison of six noninvasive tests for prediction of significant or advanced fibrosis in nonalcoholic fatty liver disease.评价和比较六种非侵入性检测用于预测非酒精性脂肪性肝病中显著或晚期纤维化。
United European Gastroenterol J. 2019 Oct;7(8):1113-1123. doi: 10.1177/2050640619865133. Epub 2019 Jul 12.
5
Transient Elastography and Ultrasonography: Optimal Evaluation of Liver Fibrosis and Cirrhosis in Patients with Chronic Hepatitis B Concurrent with Nonalcoholic Fatty Liver Disease.瞬时弹性成像和超声检查:慢性乙型肝炎合并非酒精性脂肪性肝病患者肝纤维化和肝硬化的最佳评估。
Biomed Res Int. 2019 Jan 23;2019:3951574. doi: 10.1155/2019/3951574. eCollection 2019.
6
Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients.血清细胞角蛋白-18及其与非酒精性脂肪性肝病和丙型肝炎病毒患者通过FibroScan诊断的肝纤维化及受控衰减参数测定的肝脂肪变性的关系。
Eur J Gastroenterol Hepatol. 2019 May;31(5):633-641. doi: 10.1097/MEG.0000000000001385.
7
Diagnosis of liver fibrosis in ageing patients with HIV at risk for non-alcoholic fatty liver disease in Italy and Canada: assessment of a two-tier pathway.意大利和加拿大艾滋病毒感染高危非酒精性脂肪性肝病老年患者肝纤维化的诊断:两步法评估。
Lancet HIV. 2022 Mar;9 Suppl 1:S4. doi: 10.1016/S2352-3018(22)00069-8.
8
Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Noninvasive Biomarkers and Transient Elastography.非酒精性脂肪性肝病/非酒精性脂肪性肝炎的诊断和评估,包括无创生物标志物和瞬时弹性成像。
Clin Liver Dis. 2018 Feb;22(1):73-92. doi: 10.1016/j.cld.2017.08.004.
9
Cost-Effective Evaluation of Nonalcoholic Fatty Liver Disease With NAFLD Fibrosis Score and Vibration Controlled Transient Elastography.使用非酒精性脂肪性肝病纤维化评分和振动控制瞬时弹性成像对非酒精性脂肪性肝病进行成本效益评估。
Am J Gastroenterol. 2015 Sep;110(9):1298-304. doi: 10.1038/ajg.2015.241. Epub 2015 Aug 25.
10
Non-invasive assessment of fibrosis and steatosis in pediatric non-alcoholic fatty liver disease.儿童非酒精性脂肪性肝病中纤维化和脂肪变性的无创评估
Clin Res Hepatol Gastroenterol. 2022 Jan;46(1):101755. doi: 10.1016/j.clinre.2021.101755. Epub 2021 Jul 24.

引用本文的文献

1
Why a private hospital in Mexico City embraces research.为何墨西哥城的一家私立医院热衷于开展研究。
Nature. 2022 Oct 5. doi: 10.1038/d41586-022-03139-z.

本文引用的文献

1
Towards appropriate information provision for and decision-making with patients with limited health literacy in hospital-based palliative care in Western countries: a scoping review into available communication strategies and tools for healthcare providers.在西方国家基于医院的姑息治疗中为健康素养有限的患者提供适当的信息和决策支持:针对医疗保健提供者可用的沟通策略和工具的范围综述。
BMC Palliat Care. 2019 Apr 12;18(1):37. doi: 10.1186/s12904-019-0421-x.
2
Non-alcoholic fatty liver disease and the interface between primary and secondary care.非酒精性脂肪性肝病与初级保健和二级保健之间的关系。
Lancet Gastroenterol Hepatol. 2018 Jul;3(7):509-517. doi: 10.1016/S2468-1253(18)30077-3.
3
Effectiveness of interventions to promote help-seeking for mental health problems: systematic review and meta-analysis.
干预措施促进心理健康问题寻求帮助的效果:系统评价和荟萃分析。
Psychol Med. 2018 Dec;48(16):2658-2667. doi: 10.1017/S0033291718001265. Epub 2018 Jun 1.
4
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.非酒精性脂肪性肝病和非酒精性脂肪性肝炎的全球负担:趋势、预测、危险因素和预防。
Nat Rev Gastroenterol Hepatol. 2018 Jan;15(1):11-20. doi: 10.1038/nrgastro.2017.109. Epub 2017 Sep 20.
5
The Identification of Calcified Coronary Plaque Is Associated With Initiation and Continuation of Pharmacological and Lifestyle Preventive Therapies: A Systematic Review and Meta-Analysis.钙化冠状动脉斑块的识别与药物和生活方式预防治疗的启动和持续相关:系统评价和荟萃分析。
JACC Cardiovasc Imaging. 2017 Aug;10(8):833-842. doi: 10.1016/j.jcmg.2017.01.030.
6
Efficacy of dietary and physical activity intervention in non-alcoholic fatty liver disease: a systematic review.饮食和体育活动干预对非酒精性脂肪性肝病的疗效:一项系统评价
BMJ Open Gastroenterol. 2017 Jun 1;4(1):e000139. doi: 10.1136/bmjgast-2017-000139. eCollection 2017.
7
Pathogenesis and novel treatment options for non-alcoholic steatohepatitis.非酒精性脂肪性肝炎的发病机制及新型治疗选择。
Lancet Gastroenterol Hepatol. 2016 Sep;1(1):56-67. doi: 10.1016/S2468-1253(16)30011-5. Epub 2016 Aug 10.
8
Determinants of adherence to lifestyle intervention in adults with obesity: a systematic review.肥胖成年人生活方式干预依从性的决定因素:一项系统综述。
Clin Obes. 2017 Jun;7(3):123-135. doi: 10.1111/cob.12183. Epub 2017 Mar 15.
9
Barriers and facilitators to the implementation of audio-recordings and question prompt lists in cancer care consultations: A qualitative study.癌症护理咨询中实施录音和问题提示清单的障碍与促进因素:一项定性研究。
Patient Educ Couns. 2017 Jun;100(6):1083-1091. doi: 10.1016/j.pec.2017.01.005. Epub 2017 Jan 16.
10
EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.欧洲肝脏研究学会-欧洲糖尿病研究学会-欧洲肥胖症研究学会非酒精性脂肪性肝病管理临床实践指南
Diabetologia. 2016 Jun;59(6):1121-40. doi: 10.1007/s00125-016-3902-y.